Close Menu

NEW YORK (GenomeWeb) – Quanterix said today it has entered a collaboration with Destina Genomics to explore the use of Quanterix's Simoa technology for the detection of microRNAs.

The effort will focus initially on development of an assay for detection and quantification of the liver toxicity biomarker microRNA-122.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.